Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The sensory action potentials amplitude of the median nerve increased from baseline to the end of the study
In Phase 3 clinical trials completed in December 2025, retatrutide produced an average body weight reduction of 28.7% at the highest dose over 68 weeks
Menstrual cycle effects: Some women report MOTS-c effects varying across the menstrual cycle, potentially reflecting interactions with fluctuating estrogen and progesterone
Melatonin (0.53 mg) taken 12 hours before desired sleep time can help shift sleep timing
Inconclusive No Result Your genetic data for rs1805008, a MC1R gene variant, was not successfully called by the laboratory
US$ 21.27
US$ 22.20
US$ 28.59
US$ 21.17
US$ 21.16
US$ 25.37
US$ 20.06
